Stock Price Quote

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE407.4014.9 (+3.8 %)
PREV CLOSE ( ) 392.50
OPEN PRICE ( ) 397.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 33932
TODAY'S LOW / HIGH ( )397.05 408.80
52 WK LOW / HIGH ( )386.3 690.6
NSE407.5014.85 (+3.78 %)
PREV CLOSE( ) 392.65
OPEN PRICE ( ) 399.00
BID PRICE (QTY) 407.50 (50)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 555699
TODAY'S LOW / HIGH( ) 397.10 409.00
52 WK LOW / HIGH ( )386.2 690.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-11 1977
Management Info
Glenn Saldanha - Chairman Glenn Saldanha - Managing Director
Registered Office

Address B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, ,
Mumbai,
Maharashtra-400026

Phone

Email webmaster@glenmarkpharma.com

Website www.glenmarkpharma.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

21May Glenmark Pharmaceuticals informs about
Glenmark Pharmaceuticals has informed that the US FDA has issued Form 48..
21May USFDA inspects Glenmark Pharmaceutical
The United States Food & Drug Administration (USFDA) has inspected G..
21May USFDA inspects Glenmark Pharmaceutical
The United States Food & Drug Administration (USFDA) has inspected G..
20May Glenmark Pharmaceuticals informs about
Glenmark Pharmaceuticals has informed that it attached media release tod..
20May Glenmark Pharma’s arm gets USFDA’s fin
Glenmark Pharmaceuticals’ subsidiary -- Glenmark Pharmaceuticals Inc., U..

Financials

in Millions
QTR Dec 21 ANNUAL 21
Net Profit5485.1916494.47
Gross Profit 6366.55 19437.57
Operating Profit 7272.2522865.78
Net Sales 20330.5475679.33

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddy's Lab (BSE)
peergroup  4246.30 (8.10%)
M.Cap ( in Cr)70669.41
Divi's Lab (BSE)
peergroup  4306.60 (2.53%)
M.Cap ( in Cr)114326.70
Pfizer (BSE)
peergroup  4352.00 (2.06%)
M.Cap ( in Cr)19909.41
Alkem Laboratories (BSE)
peergroup  3001.30 (2.87%)
M.Cap ( in Cr)35885.04
Torrent Pharma (BSE)
peergroup  2664.45 (2.82%)
M.Cap ( in Cr)45084.82

Shareholding Pattern

MUTUAL FUNDS/UTI 6.18%
PROMOTERS 46.65%
NON-INSTITUTION 18.27%
FI/BANKS/INSURANCE 0.44%
GOVERNMENT 0%
FII 0%

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. was incorporated in the year 1977. Its today's share price is 407.4. Its current market capitalisation stands at Rs 11495.53 Cr. In the latest quarter, company has reported Gross Sales of Rs. 75679.33 Cr and Total Income of Rs.79641.7 Cr. The company's management includes Harish Kuber, Dipankar Bhattacharjee, DR Mehta, Rajesh V Desai, Blanche Elizabeth Saldanha, Brian W Tempest, Saira Ramasastry, Sridhar Gorthi, Bernard Munos, Cherylann Pinto, VS Mani, Glenn Saldanha, Glenn Saldanha.

It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Arthur Andersen & Associates, Price Waterhouse, Suresh Surana & Associates LLP, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)